Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lux-Breast 3; Randomised Phase II Study of Afatinib Alone or in Combination With Vinorelbine Versus Investigator's Choice of Treatment in Patients With HER2 Positive Breast Cancer With Progressive Brain Metastases After Trastuzumab and/or Lapatinib Based Therapy
Status: Enrolling
Updated:  8/25/2015
Boehringer Ingelheim Investigational Site
mi
from
Columbus, OH
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lux-Breast 3; Randomised Phase II Study of Afatinib Alone or in Combination With Vinorelbine Versus Investigator's Choice of Treatment in Patients With HER2 Positive Breast Cancer With Progressive Brain Metastases After Trastuzumab and/or Lapatinib Based Therapy
Status: Enrolling
Updated: 8/25/2015
Boehringer Ingelheim Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lux-Breast 3; Randomised Phase II Study of Afatinib Alone or in Combination With Vinorelbine Versus Investigator's Choice of Treatment in Patients With HER2 Positive Breast Cancer With Progressive Brain Metastases After Trastuzumab and/or Lapatinib Based Therapy
Status: Enrolling
Updated:  8/25/2015
1200.67.11004 Boehringer Ingelheim Investigational Site
mi
from
Toronto,
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lux-Breast 3; Randomised Phase II Study of Afatinib Alone or in Combination With Vinorelbine Versus Investigator's Choice of Treatment in Patients With HER2 Positive Breast Cancer With Progressive Brain Metastases After Trastuzumab and/or Lapatinib Based Therapy
Status: Enrolling
Updated: 8/25/2015
1200.67.11004 Boehringer Ingelheim Investigational Site
mi
from
Toronto,
Click here to add this to my saved trials
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated:  8/25/2015
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated: 8/25/2015
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated:  8/25/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated: 8/25/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated:  8/25/2015
UT MD Anderson Cancer Center
mi
from
Houston, TX
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated: 8/25/2015
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated:  8/25/2015
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
Status: Enrolling
Updated: 8/25/2015
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hepatic Artery Infusion With Oxaliplatin
Hepatic Arterial Infusion of Oxaliplatin Clinical Trial
Status: Enrolling
Updated:  8/26/2015
Medical College of Wisconsin/ Froedtert Hospital
mi
from
Milwaukee, WI
Hepatic Artery Infusion With Oxaliplatin
Hepatic Arterial Infusion of Oxaliplatin Clinical Trial
Status: Enrolling
Updated: 8/26/2015
Medical College of Wisconsin/ Froedtert Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Miller Children's Hospital
mi
from
Long Beach, CA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Children's Hospital of Orange County
mi
from
Orange, CA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
University of California San Francisco Medical Center-Parnassus
mi
from
San Francisco, CA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
University of California San Francisco Medical Center-Parnassus
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Connecticut Children's Medical Center
mi
from
Hartford, CT
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Childrens National Medical Center
mi
from
Washington,
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Nemours Children's Clinic - Jacksonville
mi
from
Jacksonville, FL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Nemours Children's Clinic - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Nemours Children's Clinic - Orlando
mi
from
Orlando, FL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Nemours Children's Clinic - Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Saint Joseph Children's Hospital of Tampa
mi
from
Tampa, FL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Saint Joseph Children's Hospital of Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Univ of Illinois
mi
from
Chicago, IL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Advocate Hope Children's Hospital
mi
from
Oak Lawn, IL
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Advocate Hope Children's Hospital
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Kosair Children's Hospital
mi
from
Louisville, KY
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
C S Mott Children's Hospital
mi
from
Ann Arbor, MI
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
C S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Columbia University Medical Center
mi
from
New York, NY
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Mission Hospital
mi
from
Asheville, NC
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Mission Hospital
mi
from
Asheville, NC
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Oregon Health and Science University
mi
from
Portland, OR
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Rhode Island Hospital
mi
from
Providence, RI
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Medical University of South Carolina
mi
from
Charleston, SC
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Baylor College of Medicine
mi
from
Houston, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated:  8/26/2015
Princess Margaret Hospital for Children
mi
from
Perth,
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Status: Enrolling
Updated: 8/26/2015
Princess Margaret Hospital for Children
mi
from
Perth,
Click here to add this to my saved trials
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  8/26/2015
Yale University
mi
from
New Haven, CT
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 8/26/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  8/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 8/26/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  8/26/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 8/26/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  8/26/2015
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 8/26/2015
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated:  8/26/2015
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
A Phase 1b Dose-Escalation Study of the AKT Inhibitor MK-2206 (NSC# 749607) Plus Lapatinib (NSC# 727989) Administered in Patients With HER2 Positive Metastatic Breast Cancer
Status: Enrolling
Updated: 8/26/2015
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  8/26/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
mi
from
Baltimore, MD
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 8/26/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials